Comparative Analysis of Approaches to Assess the Quality of Inactivated Influenza Vaccines: Regulatory Requirements in the Russian Federation and European Union
The experience with the influenza pandemic caused by strain A (H1N1) 2009 and the existing gaps in standardizing and evaluating the quality and effectiveness of vaccines for influenza prevention have led the European Union (EU) to recognize the need to review / update the current guidelines on requi...
Saved in:
Main Authors: | L. M. Khantimirova, S. G. Guseva, V. A. Shevtsov, V. A. Merkulov, V. P. Bondarev |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Numikom LLC
2021-01-01
|
Series: | Эпидемиология и вакцинопрофилактика |
Subjects: | |
Online Access: | https://www.epidemvac.ru/jour/article/view/1134 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inactivated recombinant influenza vaccine: the promising direction for the next generation of influenza vaccine
by: Hua Shi, et al.
Published: (2024-12-01) -
Real-world effectiveness of live attenuated influenza vaccines (LAIV) and inactivated influenza vaccines (IIV) in children from 2003 to 2023: a systematic literature review and network meta-analysis
by: Anke L. Stuurman, et al.
Published: (2025-12-01) -
Results of a clinical study of the influenza tetravalent inactivated subunit adjuvant vaccine Grippol Quadrivalent in children aged 6 months to 5 years (inclusive)
by: Viktor V. Romanenko, et al.
Published: (2024-07-01) -
The Study in Animal Models of Local Action, Acute and Chronic Toxicity of Inactivated Influenza Vaccine Ultriks in Syringe
by: O. G. Kurskaya, et al.
Published: (2015-06-01) -
The prevention of H5N1 avian influenza: inactivated low pathogenicity avian influenza virus-based vaccine against high pathogenicity avian influenza virus strain
by: Natalya V. Moroz, et al.
Published: (2025-02-01)